Deciphera Pharmaceuticals, Inc. (DCPH) Stock Overview
Explore Deciphera Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Deciphera Pharmaceuticals, Inc. (DCPH)
Key Financials
Key Financials
Market Cap
2.2B
P/E Ratio
-11.17
EPS (TTM)
$-2.21
ROE
-0.56%
DCPH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Deciphera Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of DCPH on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $19.86 for the NASDAQ listing.
Key metrics behind Deciphera Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -11.17 and a market capitalization of 2.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DCPH on the NASDAQ.